Literature DB >> 6409423

Calcium-independent adhesion of extra-embryonic endoderm cells from the early chick blastoderm is inhibited by the blastoderm beta-D-galactoside-binding lectin and by beta-galactosidase.

N Milos, S E Zalik.   

Abstract

Extra-embryonic endoderm cells from gastrulating chick embryos possess Ca2+-dependent and Ca2+-independent adhesive mechanisms. These cells also contain an endogenous beta-D-galactoside-binding lectin and cell surface receptors bearing galactose groups. The endogenous lectin inhibits cellular adhesion. To test whether the adhesive interactions involving lectin and galactose molecules are part of the Ca2+-independent or Ca2+-dependent adhesive mechanism, dissociated cells which were preincubated in beta-galactosidase were allowed to aggregate in the presence and absence of Ca2+ ions. Significant decreases in adhesion were observed in both cases. Cells were also allowed to aggregate in the presence and absence of Ca2+ ions when blastoderm lectin was present in the medium. Adhesion was decreased in both cases. The results suggest that cell surface galactose groups and the beta-D-galactoside-binding lectin are involved in Ca2+-independent adhesion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409423     DOI: 10.1016/0045-6039(83)90014-3

Source DB:  PubMed          Journal:  Cell Differ        ISSN: 0045-6039


  3 in total

Review 1.  On the possible role of endogenous lectins in early animal development.

Authors:  S E Zalik
Journal:  Anat Embryol (Berl)       Date:  1991

2.  The endogenous lectins of the chick blastoderm are present in association with an apolipoprotein in distinct organelles and in the extracellular matrix.

Authors:  Esmond J Sanders; Sara E Zalik; Wolfgang J Schneider; Irene M Ledsham
Journal:  Rouxs Arch Dev Biol       Date:  1990-05

Review 3.  Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis.

Authors:  A Raz; R Lotan
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.